相关实验视频

Updated: May 1, 2026

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

Published on: September 6, 2016

自组装的流感纳米粒子疫苗产生广泛中和的H1N1抗体

Masaru Kanekiyo¹, Chih-Jen Wei, Hadi M Yassine

¹Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

|May 24, 2013

概括

与传统疫苗相比,使用自组装纳米颗粒的新型流感疫苗显示出更强的效力和更广泛的免疫力,对抗多种菌株. 这种基于结构的方法为未来的普遍流感病毒保护提供了基础.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
纳米技术纳米技术
疫苗开发疫苗开发

背景情况:

流感病毒对全球健康构成重大挑战,需要每年更新疫苗.
目前的流感疫苗生产依赖于过时的技术,努力跟上不断发展的病毒菌株.
来自人类和动物水库的新兴流感菌株对疫苗有效性构成持续威胁.

研究的目的:

使用蛋白质结构知识来设计一种新的流感疫苗.
创建自组装纳米颗粒,引起更广泛,更强大的免疫反应.
建立一个通用流感疫苗保护的基础.

主要方法:

将病毒血质素 (HA) 基因融合到费里丁,以创建自组装的纳米粒子.
在子单元接口上插入HA,形成显示八个三元病毒尖峰的纳米粒子.
用纳米粒子疫苗进行免疫接种,并评估抗体标位和中和能力.

主要成果:

流感纳米粒子疫苗诱导的抗体标位比授权的无活化疫苗高出十倍以上.
它引起了针对保存的HA干和头受体结合部位的中和抗体.
疫苗诱导的抗体中和了跨越1934-2007年的H1N1病毒,并保护了当代H1N1挑战.

结论:

自组装纳米颗粒的基于结构的设计增强了流感疫苗的效力和范围.
这种方法为开发通用流感疫苗提供了一个有希望的平台.
这项技术可能适用于制造针对其他病原体的疫苗.

更多相关视频

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

相关概念视频

Humoral Immune Responses

Humoral Immune Responses

Cross-reactivity

Cross-reactivity

Vaccinations

Vaccinations

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Influenza

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...